Apr 17 |
G1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024
|
Apr 12 |
Breaking Down G1 Therapeutics: 5 Analysts Share Their Views
|
Apr 4 |
G1 Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
|
Mar 22 |
Why G1 Therapeutics Is A Speculative 'Buy' In The Oncology Biotech Landscape
|
Feb 29 |
G1 Therapeutics, Inc. (NASDAQ:GTHX) Q4 2023 Earnings Call Transcript
|
Feb 29 |
Q4 2023 G1 Therapeutics Inc Earnings Call
|
Feb 28 |
G1 Therapeutics, Inc. (GTHX) Q4 2023 Earnings Call Transcript
|
Feb 28 |
G1 Therapeutics (GTHX) Reports Q4 Loss, Tops Revenue Estimates
|
Feb 28 |
G1 Therapeutics Inc (GTHX) Reports Strong Revenue Growth in 2023
|
Feb 28 |
G1 Therapeutics GAAP EPS of -$0.21 beats by $0.07, revenue of $14.9M beats by $1.87M
|